Catamount Wealth Management’s Alkermes ALKS Stock Holding History

Catamount Wealth Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-35	Closed	-$2K	–	188
2017 Q2	$2K	Buy	+35	New	+$2.03K	﹤0.01%	157

Other funds holding ALKS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Catamount Wealth Management's ALKS Position: Q3 2017 in Review

Catamount Wealth Management sold out of Alkermes (ALKS) in Q3 2017, closing a stake of 35 shares — an estimated $2K sold.

Catamount Wealth Management first reported a position in ALKS in Q2 2017 and held it in 1 quarter. The position peaked at $2K in Q2 2017. 244 funds tracked by Wall St. Rank hold ALKS as of Q3 2017.

Catamount Wealth Management reported no remaining Alkermes position as of Q3 2017 after selling out during the quarter.
Catamount Wealth Management sold 35 Alkermes shares in Q3 2017, an estimated $2K.
Catamount Wealth Management first reported a position in Alkermes in Q2 2017 and held it in 1 quarter.
Catamount Wealth Management's Alkermes position peaked at $2K in Q2 2017.
244 funds tracked by Wall St. Rank held Alkermes as of Q3 2017.

Based on Catamount Wealth Management's 13F filing for Q3 2017, filed 13 Nov 2017.